A Study in Healthy Male Subjects to Investigate Whether Administration of Rifampicin Can Affect the Fate of Clazosentan in the Body of Clazosentan

NCT03596294 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

DRUG: Clazosentan
DRUG: Rifampicin
OTHER: Saline (0.9% sodium chloride)

Sponsor

Idorsia Pharmaceuticals Ltd.